Sonoma pharmaceuticals launches microcynvs(r) line of products exclusively for veterinarian use and announces partnership with dv medical supply

Woodstock, ga / accesswire / august 2, 2022 / sonoma pharmaceuticals, inc. (nasdaq:snoa), a global healthcare leader developing and producing patented microcyn® technology based stabilized hypochlorous acid (hocl) products for a wide range of applications, including wound, eye, oral and nasal care, and dermatological conditions, today announced that it has launched a microcynvs® line of products exclusively for veterinarians. veterinarian-strength microcynvs is formulated for the management of wound, skin, ear and eye afflictions in all animal species.
SNOA Ratings Summary
SNOA Quant Ranking